Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Vaccines against avian influenza--a race against time.

Poland GA.

N Engl J Med. 2006 Mar 30;354(13):1411-3. No abstract available.

2.

An inactivated subvirion influenza A (H5N1) vaccine.

Johansson BE, Brett IC.

N Engl J Med. 2006 Jun 22;354(25):2724-5; author reply 2724-5. No abstract available.

3.

Immunogenicity, safety, and cross-reactivity of an inactivated, adjuvanted, prototype pandemic influenza (H5N1) vaccine: a phase II, double-blind, randomized trial.

Wu J, Fang HH, Chen JT, Zhou JC, Feng ZJ, Li CG, Qiu YZ, Liu Y, Lu M, Liu LY, Dong SS, Gao Q, Zhang XM, Wang N, Yin WD, Dong XP.

Clin Infect Dis. 2009 Apr 15;48(8):1087-95. doi: 10.1086/597401.

PMID:
19281330
5.

Potency of an inactivated avian influenza vaccine prepared from a non-pathogenic H5N1 reassortant virus generated between isolates from migratory ducks in Asia.

Isoda N, Sakoda Y, Kishida N, Soda K, Sakabe S, Sakamoto R, Imamura T, Sakaguchi M, Sasaki T, Kokumai N, Ohgitani T, Saijo K, Sawata A, Hagiwara J, Lin Z, Kida H.

Arch Virol. 2008;153(9):1685-92. doi: 10.1007/s00705-008-0171-1. Epub 2008 Jul 25.

PMID:
18651092
6.

Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine.

Treanor JJ, Campbell JD, Zangwill KM, Rowe T, Wolff M.

N Engl J Med. 2006 Mar 30;354(13):1343-51.

7.

A vaccine prepared from a non-pathogenic H5N1 avian influenza virus strain confers protective immunity against highly pathogenic avian influenza virus infection in cynomolgus macaques.

Itoh Y, Ozaki H, Tsuchiya H, Okamoto K, Torii R, Sakoda Y, Kawaoka Y, Ogasawara K, Kida H.

Vaccine. 2008 Jan 24;26(4):562-72. doi: 10.1016/j.vaccine.2007.11.031. Epub 2007 Dec 3.

PMID:
18164788
8.

The threat of avian influenza A (H5N1). Part IV: Development of vaccines.

Cinatl J Jr, Michaelis M, Doerr HW.

Med Microbiol Immunol. 2007 Dec;196(4):213-25. Epub 2007 Jun 1. Review.

PMID:
17541633
9.

Development of vaccines against influenza H5.

Stephenson I, Gust I, Pervikov Y, Kieny MP.

Lancet Infect Dis. 2006 Aug;6(8):458-60. No abstract available.

PMID:
16870521
10.

Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential.

Desheva JA, Lu XH, Rekstin AR, Rudenko LG, Swayne DE, Cox NJ, Katz JM, Klimov AI.

Vaccine. 2006 Nov 17;24(47-48):6859-66. Epub 2006 Jun 28.

PMID:
17050041
11.

[New steps towards an influenza A vaccine].

Nau JY.

Rev Med Suisse. 2006 May 31;2(68):1499. French. No abstract available.

PMID:
16783999
12.

[Tetravaccine--new fundamental approach to prevention of influenza pandemic].

Onishchenko GG, Zverev VV, Katlinski─ş AV, Semchenko AV, Korovkin SA, Mel'nikov SIa, Mironov AN.

Zh Mikrobiol Epidemiol Immunobiol. 2007 Jul-Aug;(4):15-9. Review. Russian.

PMID:
17882832
13.

Antibody persistence after 2-dose priming and booster response to a third dose of an inactivated, adjuvanted, whole-virion H5N1 vaccine.

Lin JT, Li CG, Wang X, Su N, Liu Y, Qiu YZ, Yang M, Chen JT, Fang HH, Dong XP, Yin WD, Feng ZJ.

J Infect Dis. 2009 Jan 15;199(2):184-7. doi: 10.1086/595832.

PMID:
19067606
14.

Inactivated whole virus influenza A (H5N1) vaccine.

Vajo Z, Kosa L, Visontay I, Jankovics M, Jankovics I.

Emerg Infect Dis. 2007 May;13(5):807-8. No abstract available.

15.

Immune responses of healthy subjects to a single dose of intramuscular inactivated influenza A/Vietnam/1203/2004 (H5N1) vaccine after priming with an antigenic variant.

Goji NA, Nolan C, Hill H, Wolff M, Noah DL, Williams TB, Rowe T, Treanor JJ.

J Infect Dis. 2008 Sep 1;198(5):635-41. doi: 10.1086/590916.

PMID:
18694338
16.

Intranasal flu vaccine protective against seasonal and H5N1 avian influenza infections.

Alsharifi M, Furuya Y, Bowden TR, Lobigs M, Koskinen A, Regner M, Trinidad L, Boyle DB, M├╝llbacher A.

PLoS One. 2009;4(4):e5336. doi: 10.1371/journal.pone.0005336. Epub 2009 Apr 29.

17.

Prospecting the influenza hemagglutinin to develop universal vaccines.

Donis RO, Cox NJ.

Clin Infect Dis. 2011 Apr 15;52(8):1010-2. doi: 10.1093/cid/cir129. No abstract available.

PMID:
21460315
18.

Efficacy of inactivated vaccines against H5N1 avian influenza infection in ducks.

Middleton D, Bingham J, Selleck P, Lowther S, Gleeson L, Lehrbach P, Robinson S, Rodenberg J, Kumar M, Andrew M.

Virology. 2007 Mar 1;359(1):66-71. Epub 2006 Oct 9.

19.

[A new step towards an influenza A H5N1 vaccine].

Nau JY.

Rev Med Suisse. 2006 May 24;2(67):1431. French. No abstract available.

PMID:
16786960
20.

Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian viruses.

Shi H, Liu XF, Zhang X, Chen S, Sun L, Lu J.

Vaccine. 2007 Oct 16;25(42):7379-84. Epub 2007 Aug 24.

PMID:
17870216

Supplemental Content

Support Center